Panacee Hospital Rama 2 - Integrative Chronic Disease & Regenerative Center
Panacee Hospital Rama 2 - Integrative Chronic Disease & Regenerative Center
Thailand, Bangkok
Clinic is certified :
Non-Hodgkin's lymphoma treatment cost in Thailand typically involves a consultation with an oncohematologist ranging from AUD $144 / ฿A4,898 to AUD $288 / ฿A9,796. Primary treatments such as chemotherapy run from AUD $2,881 / ฿A97,958 to AUD $7,203 / ฿A244,894, while bone marrow transplantation costs AUD $72,028 / ฿A2,448,944 to AUD $115,244 / ฿A3,918,311. Total expenses depend on the cancer stage and hospital type. Patients generally save 50–80% compared to costs in Australia and the United States. Key medical hubs include Bangkok and Chiang Mai.
Typical Non-Hodgkin's Lymphoma Treatment Costs in Thailand
Bookimed Expert Insight: For complex haematology cases, JCI-accredited facilities like Bumrungrad International Hospital offer high-tech care. They use AI and digital imaging to manage one million patients annually. Patients needing specialised expertise can find board-certified haematologists like Dr Kodchanut Litleaungdej. Her background includes validating cancer-associated clinical risk models. Those seeking holistic support may prefer Panacee Hospital Rama 2. It integrates ISO-certified cell therapy with traditional cancer prevention protocols.
| Thailand | Turkey | South Korea | |
| Chemotherapy for breast cancer | from AUD $4,322 / ฿A146,937 | from AUD $1,729 / ฿A58,775 | from AUD $27,659 / ฿A940,395 |
| Chemotherapy | from AUD $2,881 / ฿A97,958 | from AUD $3,501 / ฿A119,019 | from AUD $4,034 / ฿A137,141 |
| Bone marrow transplantation | from AUD $72,028 / ฿A2,448,944 | from AUD $51,860 / ฿A1,763,240 | from AUD $79,231 / ฿A2,693,839 |
| Autologous bone marrow transplantation | from AUD $57,622 / ฿A1,959,155 | from AUD $45,377 / ฿A1,542,835 | from AUD $60,503 / ฿A2,057,113 |
| Allogenic bone marrow transplantation from an unrelated donor | from AUD $216,083 / ฿A7,346,833 | from AUD $115,244 / ฿A3,918,311 | from AUD $208,881 / ฿A7,101,939 |
No hidden fees – just official clinic prices. Pay at the clinic for Non-Hodgkin's lymphoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Non-Hodgkin's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Non-Hodgkin's lymphoma treatment journey.
Dr Litleaungdej is a Thai Board-certified haematologist at Intrarat Hospital with second-class honours from Naresuan University.
Thai oncologists are highly experienced in treating international patients with Non-Hodgkin lymphoma. Major Bangkok hospitals serve over 1,000,000 patients annually. Half of these arrive from 190 different countries. Specialists often hold international board certifications and use treatments like stem cell transplantation.
Bookimed Expert Insight: Thailand’s efficiency is a major draw for Australian patients facing long public waitlists. Data shows the timeline from diagnosis to chemotherapy often takes 7 to 8 weeks. Clinics like Panacee Hospital also offer integrative care. This combines modern medicine with regenerative cell therapy.
Patient Consensus: Patients find the private hospital system in Thailand accessible and well-equipped for aggressive cancers. They suggest securing medical travel clearance early. Standard insurance often excludes pre-existing lymphoma conditions.
Bumrungrad International Hospital and Bangkok Hospital lead Thailand's treatment for Non-Hodgkin's lymphoma. These Bangkok-based centres offer JCI-accredited care, using immunotherapy and bone marrow transplants. Specialist oncologists provide precise diagnosis and advanced protocols. Most facilities feature dedicated international departments to manage patient logistics seamlessly.
Bookimed Expert Insight: Bumrungrad International Hospital's massive patient volume of 1,000,000 people annually is a key quality indicator. Half of these patients travel from 190 different countries. This high volume means their medical teams have handled nearly every lymphoma subtype. Australian patients benefit from their Global Healthcare Accreditation, which focuses specifically on international care standards.
Patient Consensus: Patients find that Thailand's tropical climate requires extra care during chemo recovery. Many recommend staying hydrated and avoiding direct sun to protect sensitive skin. Successful treatment pathways often begin with detailed characterisation of the specific lymphoma type.
Thailand provides comprehensive care for diverse Non-Hodgkin lymphoma subtypes. Specialists treat B-cell lymphomas like diffuse large B-cell lymphoma and follicular lymphoma. They also manage T-cell types and extranodal MALT lymphoma. Major Bangkok hospitals use chemotherapy, immunotherapy, and bone marrow transplants. This helps achieve high survival rates.
Bookimed Expert Insight: Many local clinics focus on basic care. However, major Bangkok centres operate on a massive scale. Bumrungrad International Hospital alone treats patients from over 190 countries. This high volume means oncohaematologists like Dr Kodchanut Litleaungdej develop deep experience. They see diverse lymphoma presentations. Patients benefit from this global expertise. It is combined with integrated cell therapies found in specialised Thai regenerative centres.
Patient Consensus: Patients note that, in Thailand, Non-Hodgkin lymphoma requires precise characterisation. It must be classified as B-cell or T-cell. They appreciate the availability of diverse treatment protocols. These include stem cell options for aggressive cases.
A bone marrow transplant for Non-Hodgkin's lymphoma in Thailand gives access to JCI-accredited facilities. These facilities have no waiting lists. Specialist centres provide autologous and allogeneic transplants using peripheral blood stem cell therapy. These procedures typically treat relapsed or aggressive cases after initial chemotherapy fails.
Bookimed Expert Insight: Thailand's infrastructure for complex haematology is driven by massive volume. Bumrungrad International Hospital alone serves over 1 million patients annually. Our data show a distinct advantage for Australians. Major Bangkok clinics hold ISO 9001:2015 and JCI certifications. These standards match Australian safety expectations. This is vital for high-risk procedures like stem cell reinfusion.
Patient Consensus: Patients note that recovery requires staying near the hospital for at least 100 days. This is to monitor immune recovery. While Thailand offers high-quality diagnostic tools, the long-term stay is a significant commitment. It is a larger commitment than first-line chemotherapy.
Non-Hodgkin lymphoma treatment in Thailand typically requires an initial stay of 2 to 4 weeks. This covers diagnosis, staging scans, and the first chemotherapy cycle. Complete protocols often involve 3 to 4 months of treatment cycles with periodic hospital admissions.
Bookimed Expert Insight: Thailand is a major hub for haematology-oncology. Bumrungrad International Hospital alone serves 500,000 international patients annually. Specialists like Dr Kodchanut Litleaungdej have advanced training in haematology from leading Thai universities. This high volume allows clinics to speed up diagnostics. They can often move from biopsy to first chemo in under 3 weeks.
Patient Consensus: Patients note that the first month is the most intensive while waiting for staging results. Most suggest planning for a 3-week initial stay in Bangkok first. Then they can discuss if their Australian GP can coordinate follow-up chemo cycles.